Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.71
Delayed Data
As of May 23
 -0.01 / -0.58%
Today’s Change
1.30
Today|||52-Week Range
3.33
+14.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues301.0K323.0K15.3M378.0K
 
 
 
 
 
Depreciation And Amortization160.0K167.0K172.0K176.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.7M13.1M14.4M15.4M
 
 
 
 
 
Research And Development10.1M9.4M11.0M11.5M
 
 
 
 
 
Total Operating Expenses13.9M13.3M14.5M15.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.6M-13.0M743.0K-15.2M
 
 
 
 
 
Interest Expense On Debt21.0K19.0K17.0K16.0K
 
 
 
 
 
Other Expenses31.0K3.0K1.0K-6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.5M-12.9M822.0K-15.1M
 
 
 
 
 
Net Income-13.5M-12.9M822.0K-15.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS121.3M121.4M146.3M149.1M
 
 
 
 
 
Shares To Calculate EPS Diluted121.3M121.4M151.9M149.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.10$0.01-$0.10
 
 
 
 
 
EPS Diluted-$0.11-$0.11$0.01-$0.10